Management is re-underwriting a specific asset or business at a value far above its cost, using fresh third-party marks
The model's full reasoning — Q2 2017 call → NOWe need to determine if management puts a concrete, externally-derived value on something the company already owns or controls, and conveys that this value is far above what the company paid, carries it at, or what the company's current results would imply. Look for specific asset, outside reference point, and value above cost. In the transcript, management discusses various assets: MS franchise, SPINRAZA, biosimilars, pipeline, etc. But do they attach a specific value to a specific holding based on external reference? They mention the biosimilar business and the option to increase investment in Samsung Bioepis. They talk about the JV and its success, but do they put a concrete value on it? They say "we are excited about the potential value" but not a specific number or external reference. They mention the licensing deal with BMS for BIIB092, but that's a cost, not a value. They mention the acquisition of Remedy Pharmaceuticals, but again cost. They talk about aducanumab, but no external valuation. They mention the contingent payments related to TECFIDERA expiring, but that's about cash flow. They mention the $400 million reallocation, but that's internal. They mention the option to opt into the JV with Samsung Bioepis, but they don't give a value. They mention the potential of the pipeline, but no specific asset valuation. They mention the value-based contracts, but that's about pricing. No specific asset is valued against an external reference point. They talk about the company's overall strategy and growth, but not a specific holding. Thus, answer NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| TTI | TETRA Technologies, Inc. | Q1 2024 | 2024-05-01 | A |
| MNKD | MannKind Corporation | Q4 2023 | 2024-02-27 | C |
| GPRE | Green Plains Inc. | Q4 2023 | 2024-02-07 | F |
| AFL | Aflac Incorporated | Q2 2023 | 2023-08-02 | C+ |
| FLR | Fluor Corporation | Q2 2022 | 2022-08-05 | D |
| IRBT | iRobot Corporation | Q3 2021 | 2021-10-28 | D |
TTI · Q1 2024 → YESThe question is: Does management put a CONCRETE, EXTERNALLY-DERIVED VALUE ON SOMETHING THE COMPANY ALREADY OWNS OR CONTROLS, and convey that this value is far above what the company paid, carries it a...YES Management identifies a specific asset: its holdings in Standard Lithium and Kodiak Gas Services (marketable securities worth slightly over $13 million, with total marketable securities around $30 million). It grounds the value in an external reference—the recent Kodiak acquisition of CSI Compressco, which made the stake “very favorable to TETRA,” plus Kodiak’s $2.5 billion market cap and strong trading volumes that allow quick, low-pressure monetization.
GPRE · Q4 2023 → YESThe question is: Does management put a CONCRETE, EXTERNALLY-DERIVED VALUE ON SOMETHING THE COMPANY ALREADY OWNS OR CONTROLS, and convey that this value is far above what the company paid, carries it a...YES Todd Becker explicitly identifies the company's ethanol plants as the specific asset being valued. He states that a high-quality plant trades in the private market at $1.80–$2.00 per gallon (or $2–$2.50 to build from scratch), while the company's overall market cap and net debt imply a lower value for its ~950 million gallon capacity.
AFL · Q2 2023 → YESThe question is: Does management put a CONCRETE, EXTERNALLY-DERIVED VALUE ON SOMETHING THE COMPANY ALREADY OWNS OR CONTROLS, and convey that this value is far above what the company paid, carries it a...YES Management identifies the specific equity stake in Varagon Capital (a minority interest they already held) and grounds its value in the external transaction where Man Group is acquiring Varagon.